Готові списки джерел за темами / AIDS (Disease) Patients Australia

Добірка наукової літератури з теми "AIDS (Disease) Patients Australia"

Автор: Grafiati

Опубліковано: 4 червня 2021

Оновлено: 4 лютого 2022

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "AIDS (Disease) Patients Australia".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "AIDS (Disease) Patients Australia":

Murray, John M., Ann M. McDonald, and Matthew G. Law. "Rapidly ageing HIV epidemic among men who have sex with men in Australia." Sexual Health 6, no. 1 (2009): 83. http://dx.doi.org/10.1071/sh08063.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

Background: Antiretroviral therapy has increased survival for individuals living with HIV and has led to an ageing of this population in developed countries. To date the rate of ageing has been unquantified, giving rise to uncertainty in the treatment emphasis and burden in this population. Methods: A mathematical model was used in conjunction with HIV/AIDS data from the Australian National HIV/AIDS Registry to estimate numbers and ages of Australian men who have sex with men (MSM) living with HIV infection from 1980 to 2005. Results: The average age of HIV-infected Australian MSM is estimated to exceed 44 years of age by the year 2010 and has increased by 1 year of age for each two calendar years since the mid-1980s. HIV-infected MSM over 60 years of age have been increasing in number by 12% per year since 1995. A consequence of successful therapy with subsequent ageing of those infected has meant that from 2001 estimated deaths from other causes exceed AIDS deaths in Australia. Conclusions: In summary, our analyses indicate an increasing and rapidly ageing population living with HIV in Australia. This will inevitably lead to more serious non-AIDS conditions in ageing patients living with HIV, and to increased treatment complexity.

Edmiston, Natalie, Erin Passmore, David J. Smith, and Kathy Petoumenos. "Multimorbidity among people with HIV in regional New South Wales, Australia." Sexual Health 12, no. 5 (2015): 425. http://dx.doi.org/10.1071/sh14070.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

Background Multimorbidity is the co-occurrence of more than one chronic health condition in addition to HIV. Higher multimorbidity increases mortality, complexity of care and healthcare costs while decreasing quality of life. The prevalence of and factors associated with multimorbidity among HIV positive patients attending a regional sexual health service are described. Methods: A record review of all HIV positive patients attending the service between 1 July 2011 and 30 June 2012 was conducted. Two medical officers reviewed records for chronic health conditions and to rate multimorbidity using the Cumulative Illness Rating Scale (CIRS). Univariate and multivariate linear regression analyses were used to determine factors associated with a higher CIRS score. Results: One hundred and eighty-nine individuals were included in the study; the mean age was 51.8 years and 92.6% were men. One-quarter (25.4%) had ever been diagnosed with AIDS. Multimorbidity was extremely common, with 54.5% of individuals having two or more chronic health conditions in addition to HIV; the most common being a mental health diagnosis, followed by vascular disease. In multivariate analysis, older age, having ever been diagnosed with AIDS and being on an antiretroviral regimen other than two nucleosides and a non-nucleoside reverse transcriptase inhibitor or protease inhibitor were associated with a higher CIRS score. Conclusion: To the best of our knowledge, this is the first study looking at associations with multimorbidity in the Australian setting. Care models for HIV positive patients should include assessing and managing multimorbidity, particularly in older people and those that have ever been diagnosed with AIDS.

McMahon, Catherine M., Bamini Gopinath, Julie Schneider, Jennifer Reath, Louise Hickson, Stephen R. Leeder, Paul Mitchell, and Robert Cowan. "The Need for Improved Detection and Management of Adult-Onset Hearing Loss in Australia." International Journal of Otolaryngology 2013 (2013): 1–7. http://dx.doi.org/10.1155/2013/308509.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

Adult-onset hearing loss is insidious and typically diagnosed and managed several years after onset. Often, this is after the loss having led to multiple negative consequences including effects on employment, depressive symptoms, and increased risk of mortality. In contrast, the use of hearing aids is associated with reduced depression, longer life expectancy, and retention in the workplace. Despite this, several studies indicate high levels of unmet need for hearing health services in older adults and poor use of prescribed hearing aids, often leading to their abandonment. In Australia, the largest component of financial cost of hearing loss (excluding the loss of well-being) is due to lost workplace productivity. Nonetheless, the Australian public health system does not have an effective and sustainable hearing screening strategy to tackle the problem of poor detection of adult-onset hearing loss. Given the increasing prevalence and disease burden of hearing impairment in adults, two key areas are not adequately met in the Australian healthcare system: (1) early identification of persons with chronic hearing impairment; (2) appropriate and targeted referral of these patients to hearing health service providers. This paper reviews the current literature, including population-based data from the Blue Mountains Hearing Study, and suggests different models for early detection of adult-onset hearing loss.

Swanson, Cheryl E., and David A. Cooper. "Factors influencing outcome of treatment with zidovudine of patients with AIDS in Australia." AIDS 4, no. 8 (August 1990): 749–58. http://dx.doi.org/10.1097/00002030-199008000-00006.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Russell, J. "6. DYADIC PERSPECTIVES ON SUPPORT FOR WOMEN LIVING WITH HIV/AIDS IN AUSTRALIA: AN EXPLORATORY STUDY." Sexual Health 4, no. 4 (2007): 286. http://dx.doi.org/10.1071/shv4n4ab6.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

There are more women than ever living with HIV/AIDS in Australia and this relatively small heterogenous population has received scant research attention. Women living with HIV/AIDS, face many complex and compelling challenges in managing this stigmatised illness in their everyday lives. This study sought to gain an understanding of these women's support needs. Semi-structured, in-depth interviews were conducted with two groups: women living with HIV/AIDS (Sydney and Melbourne, involved and not in advocacy); and HIV specialists (Sydney and Melbourne) treating women living with HIV/AIDS. There was a consensus view among both specialists and women that women: have limited knowledge of HIV/AIDS; have no collective or historical understanding of HIV/AIDS; are more likely to present late with HIV; experience diagnosis as extremely distressing; are not aware of the resources available including medical treatments; and are more likely to experience social isolation. Both groups recognised the need for psychological and social support. HIV specialists questioned the effectiveness of community based peer support, while women identified this as one of the most important forms of support. HIV specialists differed in their knowledge and views of CBOs, and this influenced their decisions on recommending these to their female patients. The unique nature of this stigmatised illness calls for the recognition of the contributions of all parties in efforts to address these support needs; the women living with HIV/AIDS, HIV specialists and community based organisations. Particularly in light of the potential for social isolation, inquiries into social structures that provide the opportunity to access social resources are arguably a future direction to advance knowledge in this area.

Martin, J., and J. Brimacombe. "Chromobacterium Violaceum Septicaemia: The Intensive Care Management of Two Cases." Anaesthesia and Intensive Care 20, no. 1 (February 1992): 88–90. http://dx.doi.org/10.1177/0310057x9202000120.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

The first human infection with Chromobacterium violaceum was recorded in 1927,1 but since men mere have been about 33 cases reported worldwide, including two from Australia.2,3 Chr. violaceum occurs in the tropics and subtropics and is generally considered to be nonpathogenic, but infection can occur in patients who are immunosuppressed4 and it has a high mortality rate.3 This paper presents the intensive care management of two cases of Chr. violaceum infection occurring in Far North Queensland. The patients’ predisposition appears to have been malnourishment and alcohol abuse. The increased use of immunosuppressive drugs and the appearance of diseases such as acquired immune deficiency syndrome (AIDS) make it possible that we will see more of this condition in Australian intensive care units.

Franceschi, Silvia, and Marco Geddes. "Epidemiology of Classic Kaposi's Sarcoma, with Special Reference to Mediterranean Population." Tumori Journal 81, no. 5 (September 1995): 308–14. http://dx.doi.org/10.1177/030089169508100502.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

An excess of classic Kaposi's sarcoma (KS) in individuals of southern European ancestry has long been suspected and recently quantified in terms of age-standardized rates. In Italy and most notably in southern Italy for the period 1976-84, prior to the AIDS epidemic, KS incidence rates were two-to-three-fold higher than in the United States and Sweden and many ten-fold higher than in England and Wales and Australia. A high frequency of classic KS has also been documented in Israel and, in low-risk countries, in individuals born in southern Europe and the Middle East. Many infections have been suspected to play a role in the etiology of KS, including cytomegalovirus, malaria and, most recently, a new virus of the herpes family, identified in AIDS-associated and classic KS. The present review deals with epidemiologic data concerning KS in the Mediterranean and stresses the opportunity to combine the study of KS in AIDS as well as non-AIDS patients in order to shed light on this no longer rare disease.

Foster, Rosalind, Sian Morris, Nathan Ryder, Lynne Wray, and Anna McNulty. "Screening of HIV-infected patients for non-AIDS-related morbidity: an evidence-based model of practice." Sexual Health 8, no. 1 (2011): 30. http://dx.doi.org/10.1071/sh10021.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

Objective: To develop guidelines to facilitate management of HIV infection as a chronic disease within the setting of a sexual health or other HIV outpatient clinic. Methods: We undertook a literature search to identify published guidelines and expert panel commentaries on screening and managing non-AIDS comorbidities in the general and HIV-infected population. We developed evidence-based guidelines for screening and management of non-AIDS comorbidities in HIV-positive clients attending the Sydney Sexual Health Centre (SSHC) that could be used in other HIV outpatient settings. Results: Guidelines have been developed that describe the recommended tests and an interpretation of results, and outline actions to take if abnormal. A summary document can be placed in the medical notes to record completed tests, and resources such as lifestyle modification pamphlets and cardiovascular risk assessment tools made easily available in clinics. Conclusions: These guidelines are being used by nurses and doctors to facilitate the management of HIV as a chronic disease in the SSHC. This represents a significant shift in practice from the traditional role of a sexual health clinic, and is likely to become increasingly important in resource-rich countries such as Australia where individuals with HIV are expected to live beyond their seventh decade. This model could be used in other HIV outpatient settings including general practice.

Thomas, S. L., K. Lam, L. Piterman, A. Mijch, and P. A. Komesaroff. "Complementary medicine use among people living with HIV/AIDS in Victoria, Australia: practices, attitudes and perceptions." International Journal of STD & AIDS 18, no. 7 (July 1, 2007): 453–57. http://dx.doi.org/10.1258/095646207781147292.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

There is limited evidence suggesting the underlying reasons for the use of complementary and alternative medicines (CAMs) by people with HIV/AIDS, or individual attitudes and beliefs about the use of CAMs. Using focus groups and a survey with 151 individuals attending the HIV Clinics at The Alfred Hospital, Melbourne, we aimed to provide insights into factors that influence the use of CAMs among people living with HIV/AIDS. Roughly half (49%) of the participants had used CAMs to manage their HIV/AIDs. Users of CAMs utilized a wide range of treatments in managing their condition, but costs of the CAMs meant that users were not necessarily able to use them as much as they might have liked. Use of CAMs was based on a desire to find something beneficial rather than on being dissatisfied with conventional medicine. Further research is needed into (a) the effects of CAMs and (b) the enhancement of communication and collaboration between patients, doctors and complementary medicine practitioners.

Chiang, Yung-Chih, Anna Collins, Prem Chopra, Ti Lu, Eng-Seong Tan, and Jeremy W. Couper. "Understanding the experiences of Mandarin-speaking patients diagnosed with life-threatening cancer in Australia." Palliative and Supportive Care 13, no. 5 (November 10, 2014): 1317–23. http://dx.doi.org/10.1017/s1478951514001175.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

AbstractObjective:People from ethnic minority groups who receive cancer care outside their country of origin may experience poor survival and psychological outcomes relative to that nation's majority groups. This exploratory qualitative study aimed to understand the experience of a large minority group of Mandarin-speaking cancer patients (MSCPs) after diagnosis and treatment of their cancer in Australia, with a view to delineate if cultural or linguistic factors affected the quality of care provided.Method:We employed an exploratory qualitative design involving interviews with 22 MSCPs who were treated during 2009 at the Peter MacCallum Cancer Centre (PMCC) in Melbourne, Australia. Participants were interviewed by a bilingual psychiatrist, audiotaped, transcribed in Mandarin, and then translated into English before being subjected to thematic analysis by two independent researchers.Results:MSCPs experienced notable challenges as a result of both language difficulties and differing cultural approaches, which often limited their understanding of their disease and impeded their ability to access quality care and adequate support. The results call for Australia and other Western nations with increasingly diverse populations to consider how cancer care can be modified to better support people from minority groups to effectively cope with their diagnosis and treatment.Significance of results:This study raises several suggestions for service improvement, including the development of bilingual communication aids, improved educational opportunities for clinical staff to aid their mastery of cultural issues and effective interpreter consultations, and improved access to supportive services offering culturally specific strategies.

Більше джерел

Дисертації з теми "AIDS (Disease) Patients Australia":

Sendziuk, Paul 1974. "Learning to trust : a history of Australian responses to AIDS." Monash University, School of Historical Studies, 2001. http://arrow.monash.edu.au/hdl/1959.1/9264.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Petoumenos, Kathy Public Health &amp Community Medicine Faculty of Medicine UNSW. "Treatment experience and HIV disease progression: findings from the Australian HIV observational database." Awarded by:University of New South Wales. School of Public Health and Community Medicine, 2006. http://handle.unsw.edu.au/1959.4/24937.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

The Australian HIV Observational Database (AHOD) is a collaboration of hospitals, sexual health clinics and specialist general practices throughout Australia, established in April 1999. Core data variables collected include demographic data, immunological and virological markers, AIDS diagnosis, antiretroviral and prophylactic treatment and cause of death. The first electronic data transfer occurred in September 1999 followed by six monthly data transfers thereafter. All analyses included in this thesis are based on patients recruited to AHOD by March 2004. By March 2004, 2329 patients had been recruited to AHOD from 27 sites throughout Australia. Of these, 352 (15%) patients were recruited from non-metropolitan clinics. The majority of patients were male (94%), and infected with HIV through male homosexual contact (73%). Almost 90% of AHOD patients are antiretroviral treatment experience, and the majority of patients are receiving triple therapy as mandated by standard of care guidelines in Australia. Antiretroviral treatment use has changed in Australia reflecting changes in the availability of new treatment strategies and agents. The crude mortality rate was 1.58 per 100 person years, and of the 105 deaths, more than half died from HIV-unrelated deaths. The prevalence of HBV and HCV in AHOD was 4.8% and 10.9%, respectively. HIV disease progression in the era of highly active antiretroviral treatment (HAART) among AHOD patients is consistent with what has been reported in developed countries. Common factors associated with HIV disease progression were low CD4 cell count, high viral load and prior treatment with mono or double therapy at the time of commencing HAART. This was demonstrated in AHOD in terms of long-term CD4 cell response, the rate of changing combination antiretroviral therapy and factors predicting death. HBV and HCV coinfection is also relatively common in AHOD, similar to other developed country cohorts. Coinfection does not appear to be serious impediments to the treatment of HIV infected patients. However, HIV disease outcome following HAART does appear to be adversely affected by HIV/HCV coinfection but not in terms of HIV/HBV coinfection. Patients attending non-metropolitan sites were found to be similar to those attending metropolitan sites in terms of both immunological response and survival.

McCarthy, Marilyn Rae. "Speaking the unspeakable : the themes, issues and concerns of seven HIV/AIDS educators in South Australia /." full text, 1993. https://www.library.health.sa.gov.au/Portals/0/speaking-the-unspeakable-the-themes-1993.pdf.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

Thesis (M. Ed.)--University of South Australia, 1993.
"Report of a thesis submitted for a masters in Education, Human Resource Studies August 1993"--Cover. Includes bibliographical references (leaf 178-188).

Hui, Wai-ting. "Serodiagnosis of Penicilliosis marneffei in HIV & non-HIV patients using a recombinant antigen Mp1p." Hong Kong : University of Hong Kong, 2000. http://sunzi.lib.hku.hk/hkuto/record.jsp?B22029746.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Walker, Blain S. "The diagnosis and treatment of major depression in AIDS patients : effect of counselor experience and attitude toward people with AIDS." Virtual Press, 1999. http://liblink.bsu.edu/uhtbin/catkey/1137581.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

This study was an investigation into the clinical judgments made by counseling psychologists when faced with a patient who had major depression and AIDS. Two hundred and eighty one counseling psychologists evaluated one of four vignettes depicting an individual with major depression. In three of the vignettes the individual also had AIDS but the vignette varied on how the virus was contracted (unprotected gay sex, IV drug abuse, hemophilia). In the fourth vignette (the control group) the individual did not have AIDS. Results of the study suggested, that the presence of AIDS overshadows the evaluation and treatment decisions made by counseling psychologists when their patient has major depression and AIDS. Three factors-counseling psychologists' general experience with people who have AIDS, their clinical experience with AIDS patients and how the AIDS virus was contracted-were investigated for possible moderating effects of the overshadowing bias. How the AIDS virus was contracted was used as an indirect measure of clinician attitude toward people with AIDS. Neither general or clinical experience with AIDS patients appeared to have an effect on the diagnostic or treatment decisions made by counseling psychologists when evaluating depressed patients with AIDS. As with experience, method of contracting the AIDS virus did not have a moderating effect on the overshadowing bias. Implications of these results for the evaluation and treatment of depression in AIDS patients, as well as future research are discussed.
Department of Counseling Psychology and Guidance Services

Grove, Teresa. "Nurses' attitudes toward patients with AIDS examined by hours of AIDS education." PDXScholar, 1990. https://pdxscholar.library.pdx.edu/open_access_etds/4071.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

This study was designed to describe the attitudes of staff nurses toward patients who have Acquired Immunodeficiency Syndrome (AIDS), and to determine if the 1989 Washington State licensing requirement for seven hours of AIDS education was effective in changing the attitudes of these nurses toward AIDS patients. Health care providers' attitudes toward patients with AIDS have been documented as differing from their attitudes toward patients with other debilitating conditions (cancer, diabetes, heart disease) in that they place more blame for getting the disease on those with AIDS, they tend to have some degree of homophobia, and they are sometimes overly cautions in using protective procedures around these patients. The consequence of these attitudes can be seen in the nursing care received by some of these patients: insensitive comments and avoidance behavior by staff.

Demling, Jennifer. "Family caregiving for persons with AIDS." Virtual Press, 1995. http://liblink.bsu.edu/uhtbin/catkey/962800.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

This study examines the experience of individuals who participated or did not participate in the caregiving process for a family member who died within approximately the past three years of an AIDS-related illness. The focus of this study is on the adjustment of the caregivers and non-caregivers after the death of the PWA. It was hypothesized that due to their direct involvement in the caregiving process, caregivers would differ significantly from non-caregivers on a number of measures designed to evaluate adjustment. It was hypothesized that caregivers would report better overall adjustment than non-caregivers.Participants completed the Symptom Checklist 90 (SCL-90; Derogatis, Lipman, & Covi, 1973), as well as a semi-structured interview about their experiences. A two-tailed t-test revealed no significant differences between groups. However, effect sizes computed for these variables revealed moderate to large diff ererences between caregivers and non-caregivers on the somatization and interpersonal subscales of the SCL-90. Comparisons to a standardization sample showed that caregivers differed significantly on all subscales from that standardization sample: Non-caregivers differed only on the depression and interpersonal sensitivity subscales. Analysis of the interview data revealed a significant difference in reported stress, with caregivers reporting significantly more stress during the illness of the PWA than non-caregivers. Effect sizes were computed for nine other interview categories; these suggested that caregiversreported substantially less social withdrawal, fewer feelings of guilt, fewer problems resolving issues with the PWA, substantially more physical illness, and more life affirming statements than their non-caregiver counterparts. Several other noteworthy trends that emerged in the interview portion of the study are discussed.Small sample size and pre-existing characteristics of the participants are explored as possible factors affecting the outcome of the study. More controlled studies exploring the adjustment of caregivers and non-caregivers are needed in order to better understand the possible differences that may exist between caregivers and non-caregivers in terms of adjustment after the death of their loved one from an AIDS-related illness.
Department of Psychological Science

Mlobeli, Regina. "HIV/AIDS Stigma: an investigation into the perspectives and expereinces of people living with HIV/AIDS." Thesis, University of the Western Cape, 2006. http://etd.uwc.ac.za/index.php?module=etd&action=viewtitle&id=gen8Srv25Nme4_6069_1189595852.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

People's attitudes towards people living with HIV/AIDS remain a major community challenge. There is a need to generate a climate of understanding, compassion and dignity in which people living with HIV/AIDS (PLWHA) will be able to voluntarily disclose their status and receive the support and respect all people deserve. However, many people expereince discrimination because they have HIV/AIDS. In a certain area in Khayelitsha, a township in Cape Town, a young woman was killed after disclosing the HIV status after being raped by five men. While many previous studies have focused on the external stigma in the general population, there is a dearth of studies on stigma among PLWHA themselves and hence the aim of the present study was to investigate stigma attached to HIV/AIDS from the perspective of PLWHA.

Baylor, Rita Atkins. "Nurses' attitudes toward caring for patients with AIDS." Virtual Press, 1992. http://liblink.bsu.edu/uhtbin/catkey/845956.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

The main purpose of this study was to examine nurses' attitudes toward caring for patients with Acquired Immune Deficiency Syndrome (AIDS). The study also compared the attitudes of nurses who had cared for AIDS patients with the attitudes of nurses who had not cared for AIDS patients. Educational background was also examined to see if education influences attitudes. The Ajzen-Fishbein Model of Reasoned Action was the framework used for this study.A descriptive design was used for the purpose of gaining more information regarding nurses' attitudes toward caring for patients with AIDS. A random sample of all registered nurses in the state of Indiana was used for this study. The data obtained were analyzed using frequency distributions, independent t-tests, and analysis of variance.Nurses in general are sill uncomfortable with caring for AIDS patients. Between 40% and 50% of nurses are fearful of contracting the AIDS virus and fearful of putting their family at risk. On the other hand, approximately the same percentage are comfortable caring for AIDS patients. Furthermore, nurses believe that health care agencies should care for AIDS patients, but believe that nurses should have the right to refuse to care for AIDS patients.Results of this study indicated that educational background does not influence nurses' attitudes toward caring for patients with AIDS. However, as nurses have more experience caring for patients with AIDS, they appear to develop more positive attitudes.
School of Nursing

Gilbert, Hannah. "Rallying resources : strategies of therapeutic engagement among patients living with HIV in Senegal." Thesis, McGill University, 2003. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=79769.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

In recent years there has been a worldwide recognition of the disparity of HIV treatment available in the West and in Sub-Saharan Africa. The West African nation of Senegal was early to implement measures that allowed for the distribution of highly effective anti-HIV therapy known as Antiretroviral (ARV) therapy to a limited number of patients. This thesis explores how patients living in Senegal who are infected with HIV have engaged in various negotiations to obtain access to treatment and other resources to meet the needs posed by their infection. These negotiations are framed by various historically embedded notions of how to engage relationships in the search for care. Strategies are also shaped by the biopolitically-laden discourse that guides the distribution of ARV therapy. This thesis traces the structure, evolution, and effects of patients' strategic negotiations in response to the introduction of this therapeutic technology.

Більше джерел

Книги з теми "AIDS (Disease) Patients Australia":

Godwin, John. Australian HIV/AIDS legal guide. Annandale, NSW: Federation Press, 1991.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Michaels, Eric. Unbecoming: An AIDS diary. Rose Bay, NSW: Empress Publishing, 1990.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Michaels, Eric. Unbecoming. Durham: Duke University Press, 1997.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Callen, Michael. Surviving AIDS. New York, NY: HarperCollins, 1990.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Callen, Michael. Surviving AIDS. New York, NY: HarperCollins, 1990.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Callen, Michael. Surviving AIDS. New York, NY: HarperPerennial, 1991.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Stewart, Gail. People with AIDS. San Diego, CA: Lucent Books, 1996.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Leslie, Mark. Dying with AIDS, living with AIDS. Dorion, Québec: Muses' Company, 1992.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Virgilio, Margherita Di, and Ivana Cucco. AIDS: Malattia, prevenzione, assistenza. Milano: FrancoAngeli, 2000.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Bessa, Marcelo Secron. Os perigosos: Autobiografias & AIDS. Rio de Janeiro: Aeroplano Editora, 2002.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Частини книг з теми "AIDS (Disease) Patients Australia":

Moulignier, A. "Cerebrovascular Disease in HIV-Infected Patients." In Cardiovascular Disease in AIDS, 131–45. Milano: Springer Milan, 2009. http://dx.doi.org/10.1007/978-88-470-0761-1_10.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Drouet, L. "Coagulative Disorders in HIV-Infected Patients." In Cardiovascular Disease in AIDS, 169–79. Milano: Springer Milan, 2009. http://dx.doi.org/10.1007/978-88-470-0761-1_13.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Barbaro, G. "Cardiological Emergencies in HIV-Infected Patients." In Cardiovascular Disease in AIDS, 203–12. Milano: Springer Milan, 2009. http://dx.doi.org/10.1007/978-88-470-0761-1_16.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Ederhy, S., C. Meuleman, N. Haddour, G. Dufaitre, F. Boccara, and A. Cohen. "Echocardiographic Findings in HIV-Infected Patients." In Cardiovascular Disease in AIDS, 75–84. Milano: Springer Milan, 2009. http://dx.doi.org/10.1007/978-88-470-0761-1_6.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Mary-Krause, M., and D. Costagliola. "Coronary Heart Disease in HIV-Infected Patients: Epidemiology." In Cardiovascular Disease in AIDS, 99–110. Milano: Springer Milan, 2009. http://dx.doi.org/10.1007/978-88-470-0761-1_8.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Tabib, A., and R. Loire. "Pathology of Peripheral and Coronary Vessels in AIDS Patients." In Cardiovascular Disease in AIDS, 65–73. Milano: Springer Milan, 2009. http://dx.doi.org/10.1007/978-88-470-0761-1_5.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Mercié, P., B. Le Bail, and C. Cipriano. "Peripheral Arterial Disease in HIV-Infected Patients: Atherosclerosis and Vasculitic Syndromes." In Cardiovascular Disease in AIDS, 147–55. Milano: Springer Milan, 2009. http://dx.doi.org/10.1007/978-88-470-0761-1_11.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Garot, J. "Cardiac MRI in Diagnosis of Myocardial Disease in HIV-Infected Patients." In Cardiovascular Disease in AIDS, 85–98. Milano: Springer Milan, 2009. http://dx.doi.org/10.1007/978-88-470-0761-1_7.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Mercié, P., B. Le Bail, and C. Cipriano. "Peripheral Arterial Disease in HIV-Infected Patients: Atherosclerosis and Vasculitic Syndromes." In Cardiovascular Disease in AIDS, 85–92. Milano: Springer Milan, 2005. http://dx.doi.org/10.1007/88-470-0358-x_8.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Boccara, F., C. Meuleman, S. Ederhy, S. Lang, S. Janower, A. Cohen, and F. Raoux. "Coronary Artery Disease in HIV-Infected Patients: ClinicalPresentation,Pathophysiology, Prognosis,Prevention,and Treatment." In Cardiovascular Disease in AIDS, 111–29. Milano: Springer Milan, 2009. http://dx.doi.org/10.1007/978-88-470-0761-1_9.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "AIDS (Disease) Patients Australia":

O’Connor, Denise, Tammy Hoffmann, Kirsten McCaffery, Christopher Maher, Ian Harris, Paul Glasziou, Laurent Billot, and Rachelle Buchbinder. "85 Evaluating a patient decision aid for people with degenerative knee disease considering arthroscopic surgery: Protocol for a randomised controlled trial." In Preventing Overdiagnosis Abstracts, December 2019, Sydney, Australia. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/bmjebm-2019-pod.98.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Lefrere, J. J., D. Vittecoq, D. Gozin, and J. Modai. "CIRCULATING ANTICOAGULANT IN AIDS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644859.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

The frequency of a circulating anticoagulant has been reported to be high in AIDS, in particular in case of Pneumocystic carinii pneumonia (Pep). Twenty-five non-hemophiliac patients (23 homosexual males,1 drug addict, 1 tranfused) with AIDS were followed over a six month period. Mean age was 32 (21-42). All patients had a markedly decreased T4/T8 ratio (mean 0.12), a low absolute T4 level (mean : 155/mm3), an elevated total serum immunoglobulins level.Activated partial thromboplastin time (APTT), prothrombintime and thrombin time were measured once a week during hospitalisation. A prolonged APTT (more than 10 seconds as compared to controls) with normal prothrombin time and thrombin time was found only once in 11patients and in two or more occasions in two others.No specific factor level of intrinsic pathway wasfound low enough to explain a prolonged APTT.Evidenceofcirculating anticoagulant (failure to correct aprolonged APTT by equal mixure of normal plasma and patient plasma) was found in all these 13 patients.Nothrombotic or haemorraghic manifestations occured.AIDS manifestations were 2 Pep.1 cytomegalovirus retinitis. 2 Kaposi's sarcomas, 1 Hodgkin's disease, 2 mycobacterium avium intracellulare pulmonary infection, 4 central nervous system toxoplasmosis, 1 Cryptococcus meningitis. Amongst the 12 patients with normal APTT,3_Pcp, 2 cytomegalovirus retinitis. 2 Kaposi's sarcomas, 2 central nervous system toxoplasmosis, 1 unexplained fever, and 2 oesophagus candidiasis were diagnosed. A transiently prolonged APTT associated to a circulating inhibitor seems to be common in AIDS. Weobserved this anomaly in 52 % (13/25). In our five cases of Pcp, 3 had normal APTT. During other opportunistic infections, the circulating inhibitor was found.The similar complications seen in two groups suggest that a circulating anticoagulant is not specifically associated to any opportunistic infection and any malignancybut appearr independently from these circumstances.

Sabih, Abdul-Hamid, Lynn Lim, Maria Cigolini, Simone I. Strasser, and Ken Liu. "IDDF2020-ABS-0176 Clinician experience and attitudes to palliative care in patients with HCC – an Australia-wide survey." In Abstracts of the International Digestive Disease Forum (IDDF), 22–23 November 2020, Hong Kong. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2020. http://dx.doi.org/10.1136/gutjnl-2020-iddf.162.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Matsushita, I., H. Motomura, T. Hiraiwa, S. Arai, C. Ota, and T. Kimura. "AB0357 The support of medical clerks in rheumatic disease clinic aids t2t practice for rheumatologists and improves disease activities of patients with rheumatoid arthritis." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.1618.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Desmyter, J. "AIDS 1987." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644751.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

AIDS virus (HIV) transmission by transfusions and blood products has been essentially halted in industrialized countries which haye introduced systematic anti-HIV screening of donations in 1985. New anti-HIV screening assays, based in part on the replacement of disrupted HIV virions by defined DNA recombinant HIV antigens, have improved specificity; sensitivity has been improved as to dectect seroconversion at an earlier stage. Confirmatory assays and (self-)exclusion of risk groups from blood donation do remain mandatory. HIVAg can be detected in some infections before antibody conversion, and HIVAg is more likely to be found in those anti-HIV positives who proceed to disease. However, there is no justification so far for routine parallel HIVAg and anti-HIV screening. There is continued uncertainty how many HIV carriers have not (yet) developed antibody, but their numbers may have been overestimated. Studies to determine how many HIV transmitters have escaped blood bank detection, and why, need to be undertaken in spite of formidable logistic difficulties.The risk of developing AIDS is now estimated at 25-50 % within 10 years after the infectious contact. It is not clear whether the risk should be estimated differently in different groups or persons. In cities in Central Africa, 5-20 % of men and women are confirmed anti-HIV positives. At least 75 % of this HIV carrier rate is due to heterosexual transmission. Heterosexual transmission has been slower in Western countries, but factors precluding slow evolution to high figures by the same route outside Africa have not been identified. Therefore, countries have no choice in advocating behaviour changes in the general population, and not only in the classical risk groups. Initial hesitations toward extended voluntary and confidential screening are dwindling. Well-conceived confidential screening may be the only way to avoid strong-armed government intervention. The latter is certain to be divisive, and is likely to be counterproductive on balance.An efficacious vaccine remains remote, but an antiviral which prolongs life by at least several months in AIDS patients, but not all of them, is now available. Zidovudine (AZT), however, is toxic and mere prolongation of life without cure will impose an additional burden on AIDS economics.A novel virus (HIV-2) has been identified and is already widespread in West-Africans. It causes AIDS, but the present ratio of AIDS cases in those infected seems lower than with HIV(-l); this feature may be transient. HIV-2 antibodies are either detected or missed by anti-HIV-1 screens; if found, they can be distinguished from anti-HIV-1 only by special confirmatory technique. New screening assays showing equal sensitivity for HIV-1 and HIV-2 in a single test should be devised. At present, HIV-2 is very rare in Western countries compared to HIV-1.

Schroeder, M., D. Shah, A. Martin, K. Ndirangu, N. Risebrough, A. Thrasis, S. Schembri, P. Bremner, M. Haberl, and A. Ismaila. "Cost-effectiveness of a Single-Inhaler Triple Therapy Versus a Dual Bronchodilator for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Australia." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7031.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Lobis, Yusuf Bachtiyar, Bhisma Murti, and Hanung Prasetya. "Influences of Peer Support Group and Psychosocio- Economic Determinants on Treatment Compliance in Hiv/Aids Patients in Sragen, Central Java." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.02.59.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

Background: Adherence to treatment is important to reduce viral replication, improve clinical and immunological conditions, reduce the risk of developing ARV resistance, and reduce the risk of HIV transmission. Peer support is suspected to be one of the factors driving drug intake adherence in patients with chronic disease. This study aimed to examine the influences of peer support and psychosocio-economic determinants on treatment compliance in HIV/AIDS patients. Subjects and Method: This was a case control design study conducted in Sragen, Central Java, Indonesia. A sample of 200 people with HIV/AIDS (PLWH) was selected by fixed disease sampling. The dependent variable was treatment compliance. The independent variables were knowledge toward HIV/AIDS, perceived benefit, perceived belief, perceived threat, perceived susceptibility, perceived seriousness, perceived barrier, attitude, indirect experience, family support, and peer support. The data were obtained from medical record and questionnaire. The data were analyzed by a multiple logistic regression run on Stata 13. Results: Treatment compliance increased with strong peer support (b= 1.34; 95% CI= 0.31 to 2.38; p= 0.011), strong family support (b= 1.09; 95% CI= 0.16 to 2.02; p= 0.021), knowledge toward HIV/AIDS (b= 1.65; 95% CI= 0.67 to 2.64; p= 0.001), high perceived benefit (b= 1.23; 95% CI= 0.28 to 2.18; p= 0.011), perceived belief (b= 2.05; 95% CI= 0.98 to 3.12; p<0.001), and high perceived threat (b= 1.22; 95% CI= 0.30 to 2.13; p= 0.009). Treatment compliance decreased with negative attitude (b= -2.47; 95% CI= -3.58 to -1.37; p <0.001), low perceived susceptibility (b= -1.26; 95% CI= -2.24 to – 0.27; p= 0.012), low perceived seriousness (b= -1.11; 95% CI= -2.06 to -0.16; p=0.021), high perceived barrier (b= -1.76; 95% CI= -2.81 to -0.70; p= 0.001), and indirect experience (b= -1.10; 95% CI= -2.05 to -0.14; p= 0.024). Conclusion: Treatment compliance increases with strong peer support, strong family support, high knowledge toward HIV/AIDS, high perceived benefit, perceived belief, and high perceived threat. Treatment compliances decrease with negative attitude, low perceived susceptibility, low perceived seriousness, high perceived barrier, and indirect experience. Keywords: HIV/AIDS, treatment compliance, peer support, psychosocial economy Correspondence: Yusuf Bachtiyar Lobis. Masters Program in Public Health, Universitas Sebelas Maret. Jl. Ir. Sutami 36A, Surakarta 57126, Central Java. Email: bachtiyar03@gmail.com. Mobile: +628111388841. DOI: https://doi.org/10.26911/the7thicph.02.59

Hansen, Laura, Manu O. Platt, Roy L. Sutliff, and Rudolph L. Gleason. "The Mechanical and Structural Changes in Murine Arteries due to the Antiretroviral Drug Azidothymidine (AZT)." In ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80799.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

With over 33 million people infected with the human immunodefeciency virus (HIV-1), HIV-1 and autoimmune deficiency syndrome (AIDS) is a worldwide epidemic [1]. However, the development and widespread use of highly active antiretroviral therapy (HAART) has helped transform HIV-1 infection from a terminal disease leading to AIDS to a manageable chronic condition. With the increase in life expectancy, a new set of non-AIDS related complications has emerged including dyslipidemia, lipodystrophy, insulin resistance, diabetes mellitus, and cardiovascular disease (CVD) specifically high risks for myocardial infarction[2] and increased incidence of atherosclerosis [3]. Additionally, patients exhibit markers of subclinical atherosclerosis including endothelial dysfunction [4], carotid artery intima-media thickening [5], and arterial stiffening [4, 6].

Shakhgildyan, V. I., M. S. Yadrikhinskaya, А. А. Orlovsky, О. Y. Shipulina, E. A. Domonova, and Е. В. Yarovaya. "CYTOMEGALOVIRUS DNA CONCENTRATION IN BIOLOGICAL SAMPLES AS A KEY TO THE DIAGNOSIS OF CMV PNEUMONIA IN HIV-INFECTED PATIENTS." In Молекулярная диагностика и биобезопасность – 2020. ФБУН Центральный НИИ эпидемиологии Роспотребнадзора, 2020. http://dx.doi.org/10.36233/978-5-9900432-9-9-86.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

According to examination and follow-up results of 5485 HIV-positive hospitalized patients (3333 of which were diagnosed with AIDS) we have identified the frequency of clinically evident CMV-infection as well as the frequency and character of CMV related lung disease. Statistically significant correlation between viral load, degree of immunosuppression, CMV replication rate and CMV pneumonia development risk has been determined. Qualitative PCR assay for CMV DNA in plasma and respiratory samples was found to have high sensitivity and low specificity for diagnosing CMV-pneumonia. We identified quantitative PCR CMV DNA values in blood cells, plasma, bronchoalveolar lavage, bronchi samples and sputum that confirm the diagnosis of CMV pneumonia with 95% and 99% probability, and exclude CMV related lung damage in HIV patients with 90% and 99% probability.

Seidl, S. "SCREENING PROCEDURES TO PREVENT TRANSMISSION OF HEPATITIS B, NON-A,NON-B, AND AIDS BY BLOOD TRANSFUSION." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644753.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

Although the number of infectious agents capable of being transmitted through blood and blood products is vast, only a few cause problems in recipients of a magnitude which warrants the need for screening tests. The most important agents are Hepatitis B Virus (HBV), Hepatitis non-A,non-B (HNANB) - agents causing posttransfusion hepatitis (PTH) and the human immundeficiency viruses (HIV) responsible for transfusion associated AIDS (TAA).PTH: Prospective studies in open-heart-surgery patients demonstrated a high prevalence (8-17%) *in Spain, Italy, the United States and Israel whereas low percentages (2-5%) were observed in Australia, Finland and West-Germany. Among haemophiliacs acute and chronic hepatitis is a rather frequent complication. Serologic markers of HBV infection have been observed in the majority of patients. Since HBsAg screening has been introduced most cases of PTH (>90%) are due to infection with HNANB-agents. For this type of hepatitis no specific assay exists. It has been suggested that surrogate tests (ALT, anti-HBc screening) might serve as interim screening measure. In prospective studies in the USA a correlation has been observed between donor ALT and recipient hepatitis, but not more than 30% of PTH can be prevented at a loss of 1,5 to 3,0% of the donor population. Similar data have been reported when blood donors were screened for anti-HBc. There was a significantly higher incidence of PTH in recipients receiving at least one unit of anti HBc positive blood. This was recently confirmed in a study in which patients received blood with ALT-levels below 30 IU/ml. The incidence of HNANB was 2,1% after transfusion with anti HBc negative blood whereas 10,1% developed HNANB when anti HB positive blood was transfused (P=< 0.0001). However, these two markers (ALT, anti HBc) do not identify the same NANB carrier population. - ALT screening and testing for anti-HBc have been recently instituted in the USA as “surrogate tests” for detecting HNANB carriers.TAA: Among the total number of AIDS cases there ist a small percentage caused by transfusion of blood and blood products. In the USA approximately 2% of TAA have been reported, 1 % of AIDS patients are haemophiliacs but the majority of haemophiliacs are HIV-antibody positive. According to a survey of the Council of Europe (March 1986) the percentages of HIV positive European haemophiliacs varies between 4 to 8% (Belgium, Norway) and 30 to 60% in other European countries. The number of TAA-cases is around 1%, AIDS among European haemophiliacs has been observed up to 5% of the total AIDS cases. - Screening for HIV antibodies in blood donors was introduced in most European countries and the USA in early summer 1985, but several thousands of recipients of HIV positive blood (issued before) are now virus carriers. This has been confirmed in “look back” programmes: A substantial number of recipient (50 to 90%) has been found to be HIV positive.-A major disadvantage of the HIV antibody test is the fact that antibodies appear several weeks after infection. The gap between infection and detecting HIV antibodies may be reduced by an antigen test, which recognizes the HIV infection as early as two weeks after infection. - The recent detection of HIV 2 implies the necessity of developing tests for the identification of variants of HIV.